Jens Hillengass, MD, PhD, is Professor of Oncology and Chief of the Myeloma and Amyloidosis Service and Vice Chair of Research of the Department of Medicine at Roswell Park Cancer Institute in Buffalo, NY. Prior to joining Roswell, he was the deputy of the section multiple myeloma of the University Hospital of Heidelberg, Germany, the leader of its autologous stem cell transplantation program, and head of the hemato-oncological imaging research group at the German Cancer Research Center (DKFZ). He completed his medical degree at Heidelberg University, where he later completed residency and fellowship in the department of hematology, oncology, and rheumatology. Dr Hillengass received a Gerok scholarship to study radiology at the German Cancer Research Center. Additionally, he completed a research fellowship at the National Cancer Institute. Dr. Hillengass is member of the International Myeloma Working Group where he co-chairs the bone and imaging group. He is also member of the guideline committee for Multiple Myeloma, Amyloidosis and Waldenstrom’s Macroglobulinemia of the National Comprehensive Cancer Network and co-chair of the myeloma committee of the Alliance for Clinical Trials.